AKT1 and acute lymphoblastic leukemia: Nevertheless, in most T-ALL clinical samples PTEN is expressed, but is inactivated due to phosphorylation by casein kinase 2 (CK2) and/or oxidation by reactive oxygen species (ROS), which results in overactive PI3K/Akt/mTOR signaling [135].